Microbe-Hacker Ginkgo Bioworks Pushes Further Into Medicine With Acquisition Of Genome Mining Platform And Antibiotics Discovery Deal With Roche

Gene-hacking unicorn Ginkgo Bioworks pushed further into medicine with the acquisition of Warp Drive Bio ' s genome mining platform and its antibiotics discovery deal with Roche. " This is a big part of the future of Ginkgo, " CEO Jason Kelly told Forbes.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news